Fundraising Fox
Auxilium Biotechnologies
San Diego, US · Founded 2019 · Delaware corporation
Find your way into Auxilium Biotechnologies
Sign up to see every warm intro you have to Auxilium Biotechnologies
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Auxilium Biotechnologies team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Auxilium Biotechnologies develops regenerative medicine devices, including the NeuroSpan Bridge, an implantable device to aid peripheral nerve regeneration. The company also works on in-space biomanufacturing, having demonstrated 3D bioprinting of implantable medical devices in microgravity aboard the ISS.
Founders & leadership
YK
Yacov KofflerNamed on SEC filing
DC
Donald CohnNamed on SEC filing
Board
CA
Craig AndrewsBoard director
MT
Mark TuszynskiBoard director
RE
Robert EnglerBoard director
Reported raises · per SEC filings
Form D private placements$7.2M disclosed across 2 rounds · 2020–2025
▶$3.9MraisedDec 2025 · 16 investors · BiotechnologyRule 506(b)
▶$3.9MraisedDec 2025 · 16 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Yacov KofflerExecutive Officer, Director
- Craig AndrewsDirector
- Mark TuszynskiDirector
- Robert EnglerDirector
- Offering amount
- $10M
- Amount sold
- $3.9M
- First sale
- Sep 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.2MraisedJan 2020 · 18 investors · BiotechnologyRule 506(b)
▶$3.2MraisedJan 2020 · 18 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Robert EnglerDirector
- Craig AndrewsDirector
- Yacov KofflerExecutive Officer, Director
- Mark TuszynskiDirector
- Donald CohnDirector
- Offering amount
- $4M
- Amount sold
- $3.2M
- First sale
- Jan 2020
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Auxilium Biotechnologies do?
- Auxilium Biotechnologies develops regenerative medicine devices, including the NeuroSpan Bridge, an implantable device to aid peripheral nerve regeneration. The company also works on in-space biomanufacturing, having demonstrated 3D bioprinting of implantable medical devices in microgravity aboard the ISS.
- How much funding has Auxilium Biotechnologies raised?
- Auxilium Biotechnologies has disclosed $7.2M raised across 2 rounds.
- Where is Auxilium Biotechnologies headquartered?
- Auxilium Biotechnologies is headquartered in San Diego, US.